PharmaTher Holdings Ltd.

The U.S. Patent and Trademark Office has granted Pharmather Holdings Ltd. (OTCQB: PHRRF) a patent for a ketamine production process. The patent, titled “Ketamine Flow Synthesis,” refers to a continuous-flow process technology for the preparation of ketamine and ketamine analogs. It...

Pharmather Holdings Ltd. (OTCQB: PHRRF) reported financial results for its third quarter ended February 28, 2022. Financial Results Cash and cash equivalents totaled CA$10,165,170 ($7,955,803) and investment totaled CA$1,666,667 ($1,304,422) for a total of CA$11,831,837 ($9,260,226) as of February...